| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.31B | +4.6% |
| Cost of Revenue | $3.41B | +2.4% |
| Gross Profit | $895.5M | +14.0% |
| R&D Expense | $135.9M | +13.5% |
| SG&A Expense | $628.1M | +8.9% |
| Operating Income | $244.8M | +17.3% |
| Interest Expense | $33.8M | -9.4% |
| Pre-tax Income | $219.0M | +21.0% |
| Income Tax | $74.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $488.4M | -1.8% |
| Inventory | $754.3M | -7.5% |
| Current Assets | $1.43B | -3.8% |
| Total Assets | $2.03B | -2.4% |
| Current Liabilities | $1.06B | -13.2% |
| Long-term Debt | $417.3M | -10.6% |
| Total Liabilities | $1.54B | -8.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $170.7M | +13.3% |
| Capital Expenditures | $47.8M | +35.0% |
| Investing Cash Flow | -$47.6M | -38.0% |
| Financing Cash Flow | -$100.1M | +0.4% |
| Free Cash Flow | $122.9M | +6.6% |
| +41.4% |
| Net Income | $142.3M | +13.0% |
| EPS (Basic) | $8.16 | +11.0% |
| EPS (Diluted) | $8.04 | +11.0% |
| Stockholders' Equity |
| $475.1M |
| +21.9% |